| 000 | 01813 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516094226.0 | ||
| 264 | 0 | _c20130317 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1879-355X | ||
| 024 | 7 |
_a10.1016/j.ijrobp.2012.04.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKalapurakal, John A | |
| 245 | 0 | 0 |
_aOutcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cFeb 2013 |
||
| 300 |
_a428-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasm Staging _xmethods |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xetiology |
| 650 | 0 | 4 |
_aNephrectomy _xmethods |
| 650 | 0 | 4 |
_aRadiotherapy _xmethods |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aSarcoma, Clear Cell _xmortality |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPerlman, Elizabeth J | |
| 700 | 1 | _aSeibel, Nita L | |
| 700 | 1 | _aRitchey, Michael | |
| 700 | 1 | _aDome, Jeffrey S | |
| 700 | 1 | _aGrundy, Paul E | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 85 _gno. 2 _gp. 428-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2012.04.023 _zAvailable from publisher's website |
| 999 |
_c21830758 _d21830758 |
||